Recommended Schedules for Pneumococcal Conjugate Vaccine

Links shared publicly online about this topic

MD Consult: News: Panel reviews recommendations for 13-valent pneumococcal conjugate vaccine

mdconsult.com — “MD Consult: News: Panel reviews recommendations for 13-valent pneumococcal conjugate vaccineView full resource at mdconsult.com

  • View Related
  • Share

Most Recently Shared on October 23, 2009 at 10:54 am By:

mdconsult MD Consult Health Site and Medical Publisher

Panel reviews recommendations for 13-valent pneumococcal conjugate vaccine http://bit.ly/3qbXWs

3 years ago...

Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine

cdc.gov — “Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide VaccineView full resource at cdc.gov

  • View Related
  • Share

Most Recently Shared on December 10, 2010 at 2:52 pm By:

HealthTrendster HealthTrendster Health Executive

RECOMMENDATIONS AND REPORTS: Prevention of Pneumococcal Disease Among Infants and Children… http://goo.gl/fb/p6HR3

1 year ago...

JAMA -- Abstract: Pneumococcal Conjugate Vaccination and Nasopharyngeal Acquisition of Pneumococcal Serotype 19A Strains, September 8, 2010, van Gils et al. 304 (10): 1099

jama.ama-assn.org — “JAMA is a highly cited weekly medical journal that publishes peer-reviewed original medical research findings and editorial opinionView full resource at jama.ama-assn.org

  • View Related
  • Share

Most Recently Shared on September 10, 2010 at 7:41 pm By:

JAMA_current JAMA Medical Journal

Dosing Schedule of Pneumococcal Vaccine Associated With Increased Risk of Acquiring Multiresistant Strain http://bit.ly/bUXuyx

2 years ago...

CDC's Advisory Committee On Immunization Practices Recommends Pfizer's Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Disease

medicalnewstoday.com — “Pfizer Inc (NYSE:PFE) announced that the United States Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) has recommended the use of Prevnar 1View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 27, 2010 at 6:09 pm By:

mnt_pharma MNT Pharma News Health News and Pharma

CDC's Advisory Committee On Immunization Practices Recommends Pfizer's Prevnar 13™ Vaccine For The Prevention Of... http://mnt.to/3yfK

2 years ago...

CDC Releases 2011 Recommended Pediatric Immunization Schedule - Physician's First Watch

firstwatch.jwatch.org — “In case you missed it in Pediatrics earlier this month, the CDC has published its annual table of recommended pediatric immunizations in MMWR. It includes updates on hepatitis B vaccination, the 13-valent pneumococcal conjugate . . . LINK(S):View full resource at firstwatch.jwatch.org

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 1:26 pm By:

yesimdem DrD Physician, Doctor, and Internist

2011 Pediatric Immunization Schedule - Physician's First Watch http://t.co/taicTyX

1 year ago...

AAP Issues 2011 Immunization Schedules - QualityPoint Technologies

qualitypointtech.net — “The American Academy of Pediatrics (AAP) has issued its recommended childhood and adolescent immunization schedules for 2011. Published in the February 2011 issue of Pediatrics (published online Feb. 1), the new schedules include guidance on administering hepatitis B vaccine to children who do not receive the recommended birth dose. They also include new information on the use of 13-valent pneumococcal conjugate vaccine, which replaced the 7-valent pneumococcal conjugate vaccine...View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on February 3, 2011 at 11:47 am By:

MedicalFeed MedicalFeed Health News Feed

AAP Issues 2011 Immunization Schedules: The American Academy of Pediatrics (AAP) has issued its recommended childh... http://bit.ly/gfnu2h

1 year ago...

Wyeth Receives Positive Opinion From European Regulators For Its 13-valent Pneumococcal Candidate Vaccine For Infants And Young Children

medicalnewstoday.com — “Wyeth pharmaceuticals, a division of wyeth (nyse: wye), announced that the european medicines agency's (emea) committee for medicinal products for human use (chmp) has issued a positive opinion foView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 28, 2009 at 8:15 pm By:

mnt_asthma MNT Asthma News Health News

Wyeth Receives Positive Opinion From European Regulators For Its 13-valent Pneumococcal Candidate Vaccine For I.. http://bit.ly/14K2rz

3 years ago...

Fewer Shots Could Still Protect Kids From Pneumonia | The Kid's Doctor: Your Partner in Parenting

kidsdr.com — “New findings show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.View full resource at kidsdr.com

  • View Related
  • Share

Most Recently Shared on July 9, 2009 at 3:39 pm By:

Medicine and Technology [part of HCPLive]: Prevention of Streptococcus pneumoniae Infections in Infants and Children

medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: Prevention of Streptococcus pneumoniae Infections in Infants and ChildrenView full resource at medicineandtechnology.com

  • View Related
  • Share

Most Recently Shared on September 27, 2010 at 11:02 am By:

DrJosephKim Joseph Kim, MD, MPH Doctor and Physician

Prevention of Streptococcus pneumoniae Infections in Infants and Children http://goo.gl/fb/ujGbB

2 years ago...

Pneumococcal vaccine for drug-resistant strains shows promise - Related Stories - AAP SmartBrief

smartbrief.com — “Study results show an investigational 13-valent pneumococcal conjugate vaccine may help eliminate new drug-resistant pneumococcal strains, researchers said. The two teams said the results are good enough for the CDC to consider suggesting FDA recommend a catch-up vaccination for children 2 to 4 yearView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on September 25, 2009 at 5:23 am By:

songMD Clara Song Pediatrician, Physician, and Doctor

Pneumococcal vaccine for drug-resistant strains shows promise http://sbne.ws/r/2Squ

3 years ago...

Updated recommendations for PCV13 - Related Stories - AAP SmartBrief

smartbrief.com — “The 13-valent pneumococcal conjugate vaccine was licensed by the FDA for prevention of invasive pneumococcal disease caused by the 13 pneumococcal serotypes covered by the vaccine and for prevention of otitis media caused by serotypes in the 7-valent pneumococcal conjugate vaccine formulation. TheView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 4:54 pm By:

Updated AAP recommendations for PCV13 - Related Stories - AAP SmartBrief

smartbrief.com — “The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed by the Food and Drug Administration for prevention of invasive pneumococcal disease caused by the 13 pneumococcal serotypes covered by the vaccine and for prevention of otitis media caused by serotypes in the 7-valent pneumococcal conView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on June 24, 2010 at 3:24 pm By:

Quick Action Can Restore Hearing After Meningitis-Induced Deafness - Ears, Nose & Throat: Allergies|Ear Infections - MSN Health & Fitness

health.msn.com — “Doing cochlear implants before cochlea hardens into bone is key researchers sayView full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on October 18, 2010 at 8:55 pm By:

msnhealthnews msn Health News

Quick Action Can Restore Hearing After Meningitis-Induced Deafness: http://on-msn.com/aTamnE

2 years ago...

Infectious Disease Article | Lung Transplantation

mdlinx.com — “Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplantsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 19, 2011 at 6:34 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent pol... http://bit.ly/fCObfX #ID

1 year ago...

Symposier - PVC13 Replaces PCV7

symposier.com — “Uploaded and Shared in Youtube by: ElsGlobalMedicalNews Dr. Joseph Bocchini summarizes the CDCs Advisory Committee on Immunization Practices recommendation to replace the current 7-valent pneumococcal conjugate vaccine with the new 13-valent version. Dr. Bocchini is professor of pediatrics and chairman of the department of pediatrics Louisiana State University, Shreveport.View full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on May 19, 2010 at 4:01 pm By:

SympoPneumology Symposier Pneumology Support

Dr. Bocchini: Recommendation to replace the current 7-valent pneumococcal conjugate vaccine with the 13-valent version. http://bit.ly/ashOkp

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • mdconsult

    MD Consult

    Twitter news features the latest medical news from MD Consult. MD Consult combines the in-depth content of tmedicine's leading books, journals, and review articles with the succinct and evidence-based point-of-care content of First Consult to provide trusted answers in one place. Physicians log over 1.7 million searches each month on MD Consult. MD Consult - Find the answer.

    View Profile

  • HealthTrendster

    HealthTrendster

    Sharing health news and trends.

    View Profile

  • JAMA_current

    JAMA

    The Journal of the American Medical Association, published since 1883, is an international peer-reviewed general medical journal published 48 times per year.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390